Archived Insight | March 30, 2020

New York Times Article on Coronavirus and Health Insurance

Segal's Ed Kaplan was included in an in-depth article in The New York Times examining the predicted effect of the coronavirus on health insurance premiums.

Read the article.

Questions about the subject of this article?

Talk to one of our consultants to get the answers you need.

What you'll find in this article

The article discusses how the pandemic has caught insurers and health plans unawares, which could lead to a huge increase in premiums next year. Some of the factors that will determine the fate of premiums include the scope of the pandemic in America, how much it costs to treat COVID-19 patients, and how much financial relief the government will provide.

Learn more from Segal

Human First. AI Forward. How to Ignite Innovation and Impact with AI

AI is reshaping business—are you ready? Get clarity & actionable steps in our upcoming webinar.

Technology, Benefits Administration, Communications, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Consulting Innovation, Corporate, Benefits Technology, ATC, Organizational Effectiveness, Health, Retirement

Business People In Meeting Having A Discussion

Reporting and Disclosure Guide for Benefit Plans 2026

The guide is an all-in-one resource that helps health and retirement plan sponsors meet compliance deadlines and avoid costly penalties.

Health, Retirement, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate, Pharmaceutical, ERISA@50

Get the Guide

Doctor Consulting With Patient During A Medical Appointment In Clinic

Q4 2025 Trends Focus: High-Cost Claims

Health plan sponsors can use data-driven strategies, preventive screenings and stop-loss coverage to lower costs and protect plan sustainability.

Health, Multiemployer Plans, Healthcare Industry, Public Sector, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

Explore all COVID-19 information

We're regularly publishing information on the coronavirus as the situation changes.

Learn More

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.